Pall Corporation v. Cuno Incorporated

681 F. Supp. 2d 258, 2010 U.S. Dist. LEXIS 4175
CourtDistrict Court, E.D. New York
DecidedJanuary 20, 2010
DocketCV 97-7599 (RRM)(ETB), CV 03-0092(RMM)(ETB)
StatusPublished
Cited by2 cases

This text of 681 F. Supp. 2d 258 (Pall Corporation v. Cuno Incorporated) is published on Counsel Stack Legal Research, covering District Court, E.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Pall Corporation v. Cuno Incorporated, 681 F. Supp. 2d 258, 2010 U.S. Dist. LEXIS 4175 (E.D.N.Y. 2010).

Opinion

MEMORANDUM OPINION AND ORDER

BOYLE, United States Magistrate Judge:

Before the court is the defendant’s motion to amend its Answer, Affirmative Defenses and Counterclaims (“Amended Answer”) to assert that the sole remaining patent at issue herein, U.S. Patent No. 5,543,047 (the “'047 Patent”), is unenforceable as a result of plaintiffs inequitable conduct during the recent reexamination proceedings that took place before the United States Patent and Trademark Office (the “PTO”). Plaintiff opposes the defendant’s motion on the grounds that the Proposed Amended Answer is not pled with particularity, as required by Federal Rule of Civil Procedure 9(b) and recent case law. For the following reasons, the defendant’s motion is granted in its entirety.

Facts

Familiarity with the facts of the underlying actions is presumed. As a result of recent reexamination proceedings before the PTO, which concluded with the issuance of a Reexamined Certificate for the '047 Patent on June 9, 2009, the plaintiff, Pall Corporation (“Pall”) found it necessary to amend its Complaint in the within two actions and did so on July 13, 2009. Pali’s Amended Complaint withdrew its infringement allegations with respect to U.S. Patent No. 5,690,765, withdrew certain allegations of willful patent infringement, and limited its claims with respect to the '047 Patent. The defendant, Cuno Incorporated (“Cuno”), did not oppose Pali’s amendment.

Although Cuno sought Pall’s consent to file its Amended Answer, Pall advised Cuno that it would oppose any such amendment. By letter motion dated July 15, 2009, Cuno requested a pre-motion conference with Judge Mauskopf with respect to its motion to amend its Answer. Judge Mauskopf referred Cuno’s letter motion to the undersigned by Order dated July 17, 2009 and, on July 24, 2009, Pall filed its letter opposing Cuno’s request for a premotion conference. By Order dated August 4, 2009, the Court waived the requirement of a pre-motion conference and granted *261 Cuno leave to move to amend its Answer by formal motion. Both parties were afforded the right to supplement their papers by Order dated November 30, 2009, due to the intervening decision in Exergen Corporation v. Wal-Mart Stores, Inc., 575 F.3d 1312 (Fed.Cir.2009), and, as permitted, Cuno submitted its revised proposed Amended Answer, for which it seeks leave to file.

Discussion

I. Legal Standard

Federal Rule of Civil Procedure 15(a) governs the amendment of pleadings and provides that “a party may amend the party’s pleading only by leave of court or by written consent of the other party; and leave shall be given as justice so requires.” Fed.R.Civ.P. 15(a). The decision to allow such leave is firmly within the discretion of the district court. See Liberty Mut. Ins. Co. v. First Brighton Transp. Mgmt., No. 07 CV 715, 2008 WL 1787684, at *4-5, 2008 U.S. Dist. LEXIS 31791, at *11-12 (E.D.N.Y. Apr. 16, 2008) (citing Zenith Radio Corp. v. Hazeltine Research, Inc., 401 U.S. 321, 330, 91 S.Ct. 795, 28 L.Ed.2d 77 (1971)). Leave to amend is generally granted unless there appears to be bad faith or unnecessary delay on the part of the movant, or permitting the proposed amendment would be futile. See Foman v. Davis, 371 U.S. 178, 182, 83 S.Ct. 227, 9 L.Ed.2d 222 (1962).

In determining whether to grant leave to amend, the court applies the same standard as that for a motion to dismiss under Rule 12(b) (6). See Dougherty v. Town of N. Hempstead Bd. of Zoning Appeals, 282 F.3d 83, 88 (2d Cir.2002). In order to defeat a Rule 12(b)(6) motion, an individual must plead only enough facts to “state a claim to relief that is plausible on its face.” Ashcroft v. Iqbal, — U.S. -, 129 S.Ct. 1937, 1949, 173 L.Ed.2d 868 (2009) (quoting Bell Atl. Corp. v. Twombly, 550 U.S. 544, 570, 127 S.Ct. 1955, 167 L.Ed.2d 929 (2007)). As such, “[t]he court must construe the facts alleged by the party proposing the amendment to be true and view them in the most favorable light.” Hartman v. County of Nassau, No. 04 CV 1784, 2008 WL 1923127, at *18, 2008 U.S. Dist. LEXIS 34729, at *55 (E.D.N.Y. Apr. 28, 2008) (citing Narvarte v. Chase Manhattan Bank, N.A., No. 96 CV 8133, 1998 WL 690059, at *1, 1998 U.S. Dist. LEXIS 15530, at *1 (S.D.N.Y. Oct. 1, 1998)).

II. Inequitable Conduct-The Elements

A finding that a patent is unenforceable due to inequitable conduct requires clear and convincing evidence of two elements: (1) that the applicant “made an affirmative misrepresentation of material fact, failed to disclose material information or submitted false material information,” and (2) that the applicant “intended to deceive” the PTO. Cargill, Inc. v. Canbra Foods, Ltd., 476 F.3d 1359, 1363 (Fed. Cir.2007) (citing Impax Labs., Inc. v. Aventis Pharms. Inc., 468 F.3d 1366, 1374 (Fed.Cir.2006)). If the court finds that the requisite two elements have been established by clear and convincing evidence, “it must then ‘balance the equities to determine whether the patentee has committed inequitable conduct that warrants holding the patent unenforceable.’ ” Cargill, 476 F.3d at 1364 (quoting Impax Labs., 468 F.3d at 1374-75) (additional citation omitted). Under this balancing test, “[t]he more material the omission or the misrepresentation, the lower the level of intent required to establish inequitable conduct, and vice versa.” Cargill, 476 F.3d at 1364 (quoting Critikon, Inc. v. Becton Dickinson Vascular Access, Inc., 120 F.3d 1253, 1256 (Fed.Cir.1997)) (alteration in original). “[A] finding of inequitable conduct in the acquisition of even a single claim of a patent renders the remaining claims of that patent unenforceable, even those without the taint of inequitable conduct.” *262 Pharmacia Corp. v. Par Pharm., Inc., 417 F.3d 1369, 1374-75 (Fed.Cir.2005) (citing Kingsdown Med. Consultants, Ltd. v. Hollister, Inc., 863 F.2d 867, 877 (Fed.Cir.1988)).

1. Materiality

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
681 F. Supp. 2d 258, 2010 U.S. Dist. LEXIS 4175, Counsel Stack Legal Research, https://law.counselstack.com/opinion/pall-corporation-v-cuno-incorporated-nyed-2010.